Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02115.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute has participated in 41 clinical trials with 4 currently active.
Therapeutic areas: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma.
Sponsors: Tufts Medical Center, ETOP IBCSG Partners Foundation, Alliance for Clinical Trials in Oncology.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute has 41 clinical trials on record, with 4 currently active. Their work covers Chronic Myeloproliferative Disorders, Leukemia, Lymphoma.
Yes — Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.